352 related articles for article (PubMed ID: 22672742)
1. Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: a pilot study.
Askmark H; Haggård L; Nygren I; Punga AR
Eur J Neurol; 2012 Dec; 19(12):1554-60. PubMed ID: 22672742
[TBL] [Abstract][Full Text] [Related]
2. Low vitamin D levels in healthy controls and patients with autoimmune neuromuscular disorders in Greece.
Chroni E; Dimisianos N; Punga AR
Acta Neurol Belg; 2016 Mar; 116(1):57-63. PubMed ID: 26183131
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency in patients with primary immune-mediated peripheral neuropathies.
Elf K; Askmark H; Nygren I; Punga AR
J Neurol Sci; 2014 Oct; 345(1-2):184-8. PubMed ID: 25115500
[TBL] [Abstract][Full Text] [Related]
4. Improvement of fatigue after vitamin D supplementation in kidney transplant recipients.
Han B; Wu X; Guo Y
Medicine (Baltimore); 2017 May; 96(21):e6918. PubMed ID: 28538382
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney disease.
Kim SM; Choi HJ; Lee JP; Kim DK; Oh YK; Kim YS; Lim CS
J Ren Nutr; 2014 Jan; 24(1):20-5. PubMed ID: 24216258
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of different vitamin D replacement strategies in patients with diabetes.
Alam U; Chan AW; Buazon A; Van Zeller C; Berry JL; Jugdey RS; Asghar O; Cruickshank JK; Petropoulos IN; Malik RA
J Diabetes Complications; 2014; 28(1):66-70. PubMed ID: 24139562
[TBL] [Abstract][Full Text] [Related]
7. The impact of routine vitamin supplementation on serum levels of 25 (OH) D3 among the general adult population and patients with chronic kidney disease.
Tareen N; Martins D; Zadshir A; Pan D; Norris KC
Ethn Dis; 2005; 15(4 Suppl 5):S5-102-6. PubMed ID: 16315388
[TBL] [Abstract][Full Text] [Related]
8. Assessment of 3-epi-25-hydroxyvitamin D levels during cholecalciferol supplementation in adults with chronic liver diseases.
Stokes CS; Volmer DA
Appl Physiol Nutr Metab; 2016 Dec; 41(12):1311-1317. PubMed ID: 27863206
[TBL] [Abstract][Full Text] [Related]
9. Effect of vitamin D supplementation on muscle energy phospho-metabolites: a ³¹P magnetic resonance spectroscopy-based pilot study.
Rana P; Marwaha RK; Kumar P; Narang A; Devi MM; Tripathi RP; Khushu S
Endocr Res; 2014; 39(4):152-6. PubMed ID: 24679100
[TBL] [Abstract][Full Text] [Related]
10. The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patients.
van den Bout-van den Beukel CJ; van den Bos M; Oyen WJ; Hermus AR; Sweep FC; Tack CJ; Bosch ME; Burger DM; Koopmans PP; van der Ven AJ
HIV Med; 2008 Oct; 9(9):771-9. PubMed ID: 18754805
[TBL] [Abstract][Full Text] [Related]
11. Low serum vitamin D levels in patients with myasthenia gravis.
Kang SY; Kang JH; Choi JC; Song SK; Oh JH
J Clin Neurosci; 2018 Apr; 50():294-297. PubMed ID: 29396067
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of micellized vs. fat-soluble vitamin D3 supplementation in healthy school children from Northern India.
Marwaha RK; Yenamandra VK; Ganie MA; Sethuraman G; Sreenivas V; Ramakrishnan L; Mathur SK; Sharma VK; Mithal A
J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1373-1377. PubMed ID: 27849624
[TBL] [Abstract][Full Text] [Related]
13. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
Leventis P; Kiely PD
Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
[TBL] [Abstract][Full Text] [Related]
14. Is vitamin D related to pathogenesis and treatment of Hashimoto's thyroiditis?
Mazokopakis EE; Papadomanolaki MG; Tsekouras KC; Evangelopoulos AD; Kotsiris DA; Tzortzinis AA
Hell J Nucl Med; 2015; 18(3):222-7. PubMed ID: 26637501
[TBL] [Abstract][Full Text] [Related]
15. Clinical improvement following vitamin D3 supplementation in Autism Spectrum Disorder.
Feng J; Shan L; Du L; Wang B; Li H; Wang W; Wang T; Dong H; Yue X; Xu Z; Staal WG; Jia F
Nutr Neurosci; 2017 Jun; 20(5):284-290. PubMed ID: 26783092
[TBL] [Abstract][Full Text] [Related]
16. Response of vitamin D binding protein and free vitamin D concentrations to vitamin D supplementation in hospitalized premature infants.
Hanson C; Lyden E; Nelson A; Thoene M; Wagner J; Wu A; Rennard S; Anderson-Berry A
J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1107-14. PubMed ID: 26030788
[TBL] [Abstract][Full Text] [Related]
17. Effects of cholecalciferol supplementation on serum and urinary vitamin D metabolites and binding protein in HIV-infected youth.
Eckard AR; Thierry-Palmer M; Silvestrov N; Rosebush JC; O'Riordan MA; Daniels JE; Uribe-Leitz M; Labbato D; Ruff JH; Singh RJ; Tangpricha V; McComsey GA
J Steroid Biochem Mol Biol; 2017 Apr; 168():38-48. PubMed ID: 28161530
[TBL] [Abstract][Full Text] [Related]
18. Effect of vitamin D
Agbalalah T; Mushtaq S
J Hum Nutr Diet; 2023 Feb; 36(1):216-225. PubMed ID: 35451536
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia.
Kubeczko M; Nowara E; Spychałowicz W; Wdowiak K; Bednarek A; Karwasiecka D; Chudek J; Wojnar J
Postepy Hig Med Dosw (Online); 2016 May; 70(0):534-41. PubMed ID: 27333923
[TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
